Prescription Drug Affordability Board

The Washington State Health Care Authority (HCA) contemplates awarding a sole source contract to IPD Analytics to provide detailed insights in the pharmaceutical pipeline for all therapies in development (new therapies and existing therapies pursuing new indications) related to their anticipated Federal Drug Administration (FDA) approval review dates (PDUFA dates), impact on clinical practice, and economic impact on payors.